Jay Barth

Jay Barth

Company: Lexeo Therapeutics

Job title: Executive Vice President & Chief, Medical Officer


Discovering Gene therapy for APOE4-Associated Alzheimer’s Disease 11:00 am

Reviewing the role of APOE in the pathogenesis of Alzheimer’s Disease Understanding the approach of AAV-based gene therapy to treat Alzheimer’s Disease patients who are APOE homozygous Describing the Phase 1 study design of LX1001Read more

day: Track B - Day 2

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.